Composition and method for improving sleep duration and quality
US10568939B2 · kind B2 · utility
Assignee
Inventors
Key dates
| Filing date | Jul 3, 2019 |
| Grant date | Feb 25, 2020 |
| Priority date | — |
| Expiry date | Jul 3, 2039 |
Classification
- Technology area (CPC A)Human Necessities
- CPC primaryA61K36/28
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
An intervention for sleep disorders comprises collagen, a gelatin peptide, or the amino acid glycine; L-theanine; lactucopicrin, deoxylactucopicrin, or another lactucopicrin derivative; hyaluronic acid; epigallocatechin gallate; and quinic acid. The intervention helps regulate pro-inflammatory biomarkers that are often associated with insomnia development and progression. These biomarkers include cytokines and enzymes associated with tryptophan degradation. Inhibition of these enzymes and cytokines improves tryptophan availability and sleep quality, and allows individuals to sleep better with fewer side effects. The novel composition promotes high-quality, deep sleep.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.